Cooperative Dual-Activity Targeted Nanomedicine for Specific and Effective Prostate Cancer Therapy-Reference-Cited by-同舟云学术

Cooperative Dual-Activity Targeted Nanomedicine for Specific and Effective Prostate Cancer Therapy

Published:2012-01-24 Issue:2 Volume:6 Page:1795-1805
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Yang Hung-Wei¹,Hua Mu-Yi¹,Liu Hao-Li²,Tsai Rung-Ywan³,Chuang Cheng-Keng⁴⁵,Chu Po-Chun²,Wu Pei-Yi⁵,Chang Ying-Hsu⁵,Chuang Heng-Chang⁵,Yu Kai-Jie⁵,Pang See-Tong⁴⁵

Affiliation:

1. Chang Gung Molecular Medicine Research Center, Department of Chemical and Materials Engineering, Chang Gung University, Kuei-Shan, Tao-Yuan 33302, Taiwan R.O.C.

2. Department of Electrical Engineering, Chang-Gung University, Kuei-Shan, Tao-Yuan 33302, Taiwan R.O.C.

3. Electronics and Optoelectronics Research Laboratories, Industrial Technology Research Institute, Hsinchu 31040, Taiwan R.O.C.

4. Graduate Institute of Clinical Medical Sciences, Chang Gung University, 259 Wen-Hwa first Road, Kuei-Shan, Tao-Yuan 33302, Taiwan R.O.C.

5. Department of Urology, Chang Gung Memorial Hospital, Tao-Yuan 33305, Taiwan R.O.C.

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/nn2048526

Reference47 articles.

1. Diagnostic and prognostic markers for human prostate cancer

2. Cancer Statistics, 2005

3. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries

4. Trends and characteristics in prostate cancer mortality in Japan

5. Recent Developments in the Epidemiology of Prostate Cancer

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy;Frontiers in Immunology;2024-05-21

2. A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century;Advanced Materials;2024-01-17

3. Nanocarrier-mediated delivery for targeting for prostate cancer;Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy;2024

4. Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells;Pharmaceutics;2023-07-03

5. Paclitaxel-Loaded Lipid-Coated Magnetic Nanoparticles for Dual Chemo-Magnetic Hyperthermia Therapy of Melanoma;Pharmaceutics;2023-03-02